NEW YORK (GenomeWeb) – OpGen announced today that it has partnered with Beth Israel Deaconess Medical Center (BIDMC) on a verification study for OpGen's Acuitas AMR Gene Panel u5.47 Assay and the Acuitas Lighthouse Knowledgebase. The study will be among the first to examine potential diagnostic and antibiotic decision-making improvements that may be possible using rapid molecular testing and bioinformatics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jul
10
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Jul
25
Sponsored by
Streck

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.